FDA green light for Fasenra
admin 29th August 2019 Uncategorised 0Currently there are no FDA-approved treatments for eosinophilic oesophagitis. More: FDA green light for Fasenra Source: News
read more
Currently there are no FDA-approved treatments for eosinophilic oesophagitis. More: FDA green light for Fasenra Source: News
read moreThe drug achieved a statistically-significant and clinically-meaningful reduction in disease activity. More: AZ bags positive results in investigational Lupus drug trial Source: News
read moreThe approval of the monoclonal antibody was based on results from the Phase III IMpassion130 study. More: EU approval for Tecentriq combo Source: News
read moreSanofi and Regeneron have been battling with PCSK9 rival Amgen over patents for their cholesterol drugs for years, with Amgen at one point securing an injunction against sales of the partners’ Praluent. Now, Sanofi and Regeneron have persuaded a judge that
read moreSterile drugs are susceptible to microbial contamination and so the water used to make ingredients need to be clean. An Indian API maker has been given that message loud and clear in a warning letter issued by the FDA. More:
read moreA 10-year wait obviously didn’t discourage Kyowa Kirin from changing the FDA’s mind for its add-on Parkinson’s therapy. Rejected by the FDA in 2008, the pharma’s Nourianz has finally secured a U.S. go-ahead, six years after it was launched in
read more© 1994 - 2026 B.M. Pharmaceuticals